Physician profile
Nirav K Shah
NPI 1770783888
$1,492.15
in general payments reported to CMS, 2019-2025
13 companies · $463 in 2025
The $463 reported for 2025 was more than what 90% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $239 · 2020: $149 · 2022: $193 · 2023: $261 · 2024: $188 · 2025: $463.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $911.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $911.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $315.29 | 2022-2023 | Senza |
| Becton, Dickinson and Company | $225.25 | 2025 | Hemosphere |
| Spr Therapeutics, INC | $169.35 | 2020-2022 | |
| Curonix LLC | $130.15 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Vertiflex, INC. | $121.30 | 2019 | |
| Stryker Corporation | $117.38 | 2019 | |
| Nalu Medical, INC. | $106.60 | 2024-2025 | Nalu Neurostimulation System |
| Novartis Pharmaceuticals Corporation | $91.14 | 2023 | |
| Edwards Lifesciences Corporation | $76.07 | 2023-2024 | Hemosphere |
| Vertex Pharmaceuticals Incorporated | $46.09 | 2024-2025 | |
| Pacira Pharmaceuticals Incorporated | $44.83 | 2024 | Exparel, Iovera, Zilretta |
| Merck Sharp & Dohme LLC | $30.38 | 2025 | Bridion |
| Moximed, INC | $18.32 | 2025 | Misha Knee System, Small, Left |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nirav Shah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.